220424-73-7 Usage
Uses
Used in Pharmaceutical Industry:
BOC-(R)-GAMMA-(3-PHENYL-PROPYL-BENZYL)-L-PROLINE is used as a building block for the synthesis of various pharmaceuticals and bioactive molecules. Its unique structure and functional groups make it a valuable component in the development of new drugs with potential therapeutic applications.
Used in Medicinal Chemistry Research:
BOC-(R)-GAMMA-(3-PHENYL-PROPYL-BENZYL)-L-PROLINE is utilized as a key component in medicinal chemistry research to explore its potential therapeutic properties. Its ability to modulate biological processes makes it a promising candidate for drug development, particularly in the areas of disease treatment and prevention.
Used in Drug Discovery:
BOC-(R)-GAMMA-(3-PHENYL-PROPYL-BENZYL)-L-PROLINE is employed in drug discovery efforts to identify and develop new therapeutic agents. Its unique chemical structure and potential to modulate biological processes contribute to the advancement of novel drug candidates with improved efficacy and safety profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 220424-73-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,0,4,2 and 4 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 220424-73:
(8*2)+(7*2)+(6*0)+(5*4)+(4*2)+(3*4)+(2*7)+(1*3)=87
87 % 10 = 7
So 220424-73-7 is a valid CAS Registry Number.
220424-73-7Relevant academic research and scientific papers
HEPATITIS C INHIBITOR PEPTIDE ANALOGUES
-
, (2008/06/13)
Compound of formula (I) active against the Hepatitis C virus: wherein B is an acyl derivative; a is 0 or 1; R6, when present, is carboxy(lower)alkyl; b is 0 or 1; R5, when present, is C1-6 alkyl, or carboxy (lower)alkyl; Y is H or C1-6 alkyl; R4 is C1-10 alkyl; R3 is C1-10 alkyl; W is -NH-CH(R2)-C(O)-, wherein R2 is C1-6 alkyl; C6 or C10 aryl; C7-16 aralkyl; or carboxy (lower)alkyl; or W is a proline derivative; Q is a group of the formula -Z(R1)-C(O)-R13, wherein Z is CH or N; R1 is C1-6 alkyl or C1-6 alkenyl both optionally substituted with thio or halo,; and R13 is an activated carbonyl substituent, or Q is a phosphonate group of the formula -CH(R1)-P(O)R15R16 wherein R15 and R16 are independently C6-20 aryloxy; and R1 is as defined above.
Hepatitis C inhibitor peptides
-
, (2008/06/13)
Disclosed herein are hepatitis C viral protease inhibitors of formula (I): wherein a is0or1; b is0or1; Y is H or C1-6alkyl; B is H, an acyl derivative or a sulfonyl derivative; R6, when present, is C1-6alkyl substituted wi
Hepatitis C inhibitor peptide analogues
-
, (2008/06/13)
Compound of formula (I) active against the Hepatitis C virus: wherein B is an acyl derivative; a is 0 or 1; R6, when present, is carboxy(lower)alkyl; b is 0 or 1; R5, when present, is C1-6 alkyl, or carboxy (lower)alkyl; Y is H or C1-6 alkyl; R4 is C1-10
